Volume 7 Issue 1, Jan 2022

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)
Volume 7 Issue 1, Jan 2022:
Research Highlight
Acquired cancer tyrosine kinase inhibitor resistance: ROS as critical determinants
Sander Bekeschus  ORCID: orcid.org/0000-0002-8773-8862